© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com
Adamis Pharmaceuticals Corporation (ADMP) stock surged +0.85%, trading at $0.78 on NASDAQ, up from the previous close of $0.77. The stock opened at $0.75, fluctuating between $0.75 and $0.79 in the recent session.
Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease in the United States. The company's product candidates comprise SYMJEPI epinephrine pre-filled syringe injectable products for use in the emergency treatment of acute allergic reactions, including anaphylaxis; dry powder inhaler products for the treatment of asthma; and naloxone injection for the treatment of opioid overdose. It also offers APC400, a tempol gel use of reducing radiation dermatitis in patients undergoing treatment for cancer; and APC410 for the treatment of respiratory diseases, including asthma, respiratory syncytial virus, influenza, and COVID-19. In addition, the company provides corticosteroids, hormone replacement therapies, hospital outsourcing products, and injectables; and veterinary pharmaceutical products for animals. Adamis Pharmaceuticals Corporation was founded in 2006 and is headquartered in San Diego, California.
Employees | 11 |
Beta | 1.28 |
Sales or Revenue | $4.76M |
5Y Sales Change% | -1% |
Fiscal Year Ends | December |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) stock price is $0.78 in the last trading session. During the trading session, ADMP stock reached the peak price of $0.79 while $0.75 was the lowest point it dropped to. The percentage change in ADMP stock occurred in the recent session was 0.85% while the dollar amount for the price change in ADMP stock was $0.01.
The NASDAQ listed ADMP is part of Drug Manufacturers - Specialty & Generic industry that operates in the broader Healthcare sector. Adamis Pharmaceuticals Corporation designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Mr. David C. Benedicto
Chief Financial Officer
Ms. Karen K. Daniels
Vice President of Operations
Mr. Robert B. Rothermel
Consultant
Ms. Jennifer C. Suski
Senior Director of Marketing
Dr. Ebrahim Versi M.D., Ph.D.
Chief Executive Officer & Chair of the Board
Mr. Eddie Wabern Glover
Chief Executive Officer of US Compounding Inc
Mr. David J. Marguglio
Co-Founder, Interim Chief Financial Officer. Pres & Chief Operating Officer
Mr. Mark Flather
Vice President of Corporation Strategy & Capital Markets
ADMP's closing price is 72.03% higher than its 52-week low of $0.45 where as its distance from 52-week high of $21.70 is -96.43%.
Number of ADMP employees currently stands at 11.
Official Website of ADMP is: https://www.adamispharmaceuticals.com
ADMP could be contacted at phone 858 997 2400 and can also be accessed through its website. ADMP operates from 11682 El Camino Real, San Diego, CA 92130, United States.
ADMP stock volume for the day was 119.48K shares. The average number of ADMP shares traded daily for last 3 months was 3.11M.
The market value of ADMP currently stands at $7.25M with its latest stock price at $0.78 and 9.36M of its shares outstanding.